Presentation TCT 2016 2016 CTO Revascularization Update Presenter: Sripal Bangalore, George D. Dangas, Khaldoon Alaswad November 01, 2016
Presentation TCT 2016 Case Conclusion: How Did We Revascularize This Patient? Presenter: John D. Puskas, Gregg W. Stone, Michael E. Halkos November 01, 2016
Presentation TCT 2016 Case Introduction: How Would You Revascularize This Patient? Presenter: John D. Puskas, Gregg W. Stone, Michael E. Halkos November 01, 2016
Presentation TCT 2016 Announcing the NIH-sponsored HYBRID Revascularization Trial Presenter: John D. Puskas, Gregg W. Stone November 01, 2016
Presentation TCT 2016 Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study) Presenter: John D. Puskas, Gregg W. Stone November 01, 2016
Presentation TCT 2016 Hybrid Coronary Revascularization: Rationale, Procedure Alternatives, and Technical Considerations Presenter: John D. Puskas, Gregg W. Stone, John S. Douglas Jr November 01, 2016
Presentation TCT 2016 Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System: Routine Use to Perform Carotid Revascularization in Symptomatic and Increased Stroke Risk Asymptomatic Patients: The PARADIGM All-Comer Prospective Study Presenter: Robert M. Bersin, John R. Laird Jr., Piotr Musialek November 01, 2016
Presentation TCT 2016 Long Term Outcomes after Revascularization of Long SFA Occlusions with OCT Guided Atherectomy OCELOT Catheter: Results from the Pivotal FIH Study Presenter: Michael D. Dake, Kenneth Rosenfield, Przemek Nowakowski November 01, 2016
News Industry News TCT 2016 Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures November 01, 2016
News Industry News Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque November 01, 2016
Presentation TCT 2016 The Impact of Ventricular Dysfunction on Prognosis After Coronary Revascularization Presenter: Ulrich P. Jorde, William W. O'Neill, Eric Jose Velazquez October 31, 2016
Presentation TCT 2016 When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Gregg W. Stone October 31, 2016
Presentation TCT 2016 Outcome-Derived FFR Threshold for Revascularization: Data From the IRIS FFR Registry (N=7,013) Presenter: Seung-Jung Park, Alan C. Yeung, Jung-Min Ahn October 31, 2016
Presentation TCT 2016 TCT 262: Clinical Outcomes of Deferred Revascularization Using Fractional Flow Reserve in Patients With and Without Diabetes Mellitus Presenter: Kevin J. Beatt, Frederick Feit October 31, 2016
Presentation TCT 2016 Coronary Revascularization in Severe Heart Failure: STICH and Beyond Presenter: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld, Robert E. Michler October 31, 2016
Presentation TCT 2016 TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial Presenter: Kevin J. Beatt, Frederick Feit October 31, 2016
Presentation TCT 2016 Multivessel CAD in STEMI Patients With Shock: Complete Revascularization or Culprit Only? Presenter: Ran Kornowski, Michel R. Le May, Henning Kelbæk October 31, 2016
Presentation TCT 2016 TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation Presenter: Michael J. Cowley, Franz-Josef Neumann, Shunsuke Kubo October 31, 2016
Presentation TCT 2016 TCT 63: Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction Presenter: Julinda Mehilli, Georgios Sianos, Philippe Généreux October 31, 2016
News Industry News TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies October 31, 2016